Antiviral pharma Chimerix gets $81M contract for smallpox countermeasure
Links shared publicly online about this topic.
- 501total visits
Antiviral pharma Chimerix gets $81M contract for smallpox countermeasure
Release of smallpox as a bioterrorism weapon is a possibility that antiviral company Chimerix has been awarded $81 million to combat. The federal contract will be used to develop the Durham, North Carolina company's antiviral drug candidate into a smallpox treatment.
View full resource at medcitynews.com
Most Recently Shared on March 12, 2011 at 7:27 pm By:
Antiviral pharma Chimerix gets $81M contract for smallpox countermeasure http://bit.ly/eEW8JN
Advertisement
